ASLAN Pharmaceuticals Ltd (ASLN)
NASDAQ
The current ASLN market cap is 1.7M. The company's latest EPS is USD and P/E is N/A.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
TWD (TWD) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 12M | 0 | 0 | 0 |
Operating Income | -18.11M | -2.36M | -10.42M | -12.85M | -9.29M |
Net Income | -19.11M | -1.89M | -9.71M | -13.51M | -9.92M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
TWD (TWD) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 92.36M | 0 | 0 | 0 | 12M |
Operating Income | -1.41B | -16.48M | -34.25M | -48.32M | -43.74M |
Net Income | -1.45B | -16.2M | -31.59M | -51.38M | -44.22M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
TWD (TWD) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 60.32M | 55.21M | 44.64M | 24.63M | 20.99M |
Total Liabilities | 50.43M | 48.84M | 45.52M | 37.91M | 38.95M |
Total Equity | 9.89M | 6.37M | -882k | -13.29M | -17.97M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
TWD (TWD) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 699.39M | 16.08M | 94.52M | 61.19M | 24.63M |
Total Liabilities | 717.46M | 26.23M | 37.21M | 52.82M | 37.91M |
Total Equity | -18.07M | -10.15M | 57.3M | 8.37M | -13.29M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
TWD (TWD) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | N/A | -37.33M | N/A | -46.64M | N/A |
Investing | N/A | 270k | N/A | 269k | N/A |
Financing | N/A | 21.1M | N/A | 10.72M | N/A |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
TWD (TWD) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -796.12M | -15.05M | -34M | -38.41M | -46.64M |
Investing | 167k | 1,000 | -28k | 415k | 269k |
Financing | 583.68M | 7.17M | 109.87M | 4.72M | 10.72M |
Market Cap | 1.7M |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 2.83M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0%) |
Company Name | ASLAN Pharmaceuticals Ltd |
Address |
190 elgin avenue george town 1-9005 |
Website | https://www.aslanpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.